Diabetologia at 50: celebrating half a century of progress in diabetes research and care Juleen R. Zierath Editorial 27 May 2015 Pages: 1685 - 1687
Future of muscle research in diabetes: a look into the crystal ball Michael Roden Commentary 24 May 2015 Pages: 1693 - 1698
Hepatokines: unlocking the multi-organ network in metabolic diseases Alison IrozJean-Pierre CoutyCatherine Postic Commentary 02 June 2015 Pages: 1699 - 1703
The future of brown adipose tissues in the treatment of type 2 diabetes Patrick SchrauwenWouter D. van Marken LichtenbeltBruce M. Spiegelman Commentary 09 May 2015 Pages: 1704 - 1707
50 years forward: mechanisms of hyperglycaemia-driven diabetic complications Nicholas D. F. RussellMark E. Cooper Commentary 24 April 2015 Pages: 1708 - 1714
Vascular AGE-ing by methylglyoxal: the past, the present and the future Casper G. Schalkwijk Commentary Open access 12 May 2015 Pages: 1715 - 1719
Comparative genomics: beyond the horizon of the next research grant Frans Schuit Commentary 14 May 2015 Pages: 1720 - 1724
Genomic medicine at the heart of diabetes management Mark I. McCarthy Commentary 10 April 2015 Pages: 1725 - 1729
The erosion of physical activity in Western societies: an economic death march Frank W. BoothJohn A. Hawley Commentary 08 May 2015 Pages: 1730 - 1734
Medications for type 2 diabetes: how will we be treating patients in 50 years? Steven E. KahnJohn B. Buse Commentary 14 March 2015 Pages: 1735 - 1739
Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years? Bo Ahrén Commentary 20 March 2015 Pages: 1740 - 1744
Incretin-based therapies: where will we be 50 years from now? Juris J. MeierMichael A. Nauck Commentary 21 May 2015 Pages: 1745 - 1750
GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial Özlem GögebakanMartin A. OsterhoffAndreas F. H. Pfeiffer Article 21 May 2015 Pages: 1759 - 1768
Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes Laurence G. TrahairMichael HorowitzKaren L. Jones Article 06 June 2015 Pages: 1769 - 1778
All-cause mortality in a nationwide cohort of childhood-onset diabetes in Norway 1973–2013 Vibeke GagnumLars C. SteneTorild Skrivarhaug Article 14 May 2015 Pages: 1779 - 1786
OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis Olli HelminenSusanna AspholmMikael Knip Article 19 May 2015 Pages: 1787 - 1796
Inverse association between fasting plasma glucose and risk of ventricular arrhythmias Francesco ZaccardiDavid R. WebbJari A. Laukkanen Article 03 June 2015 Pages: 1797 - 1802
Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial The Look AHEAD Research Group Article 14 May 2015 Pages: 1803 - 1813
Delta cell death in the islet of Langerhans and the progression from normal glucose tolerance to type 2 diabetes in non-human primates (baboon, Papio hamadryas) Rodolfo Guardado MendozaCarla PeregoFranco Folli Article 07 June 2015 Pages: 1814 - 1826
Involvement of long non-coding RNAs in beta cell failure at the onset of type 1 diabetes in NOD mice Anna MotterleSonia GattescoRomano Regazzi Article 03 June 2015 Pages: 1827 - 1835
The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice Jason M. SpaethChad S. HunterRoland Stein Article 29 May 2015 Pages: 1836 - 1844
Type 2 diabetes alters metabolic and transcriptional signatures of glucose and amino acid metabolism during exercise and recovery Jakob S. HansenXinjie ZhaoCora Weigert Article 12 June 2015 Pages: 1845 - 1854
A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control Noha A. YousriDennis O. Mook-KanamoriKarsten Suhre Article Open access 07 June 2015 Pages: 1855 - 1867
Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice Tadasuke KomoriMinoru TanakaYoshihiro Morikawa Article 14 May 2015 Pages: 1868 - 1876
Insulin regulates Rab3–Noc2 complex dissociation to promote GLUT4 translocation in rat adipocytes Francoise KoumanovVinit J. PereiraGeoffrey D. Holman Article Open access 30 May 2015 Pages: 1877 - 1886
Intestinal mTOR regulates GLP-1 production in mouse L cells Geyang XuZiru LiWeizhen Zhang Article 03 June 2015 Pages: 1887 - 1897
Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes Anne-Sophie SejlingKai H. W. LangeUlrik Pedersen-Bjergaard Article 19 May 2015 Pages: 1898 - 1906
Insulin-induced changes in skeletal muscle microvascular perfusion are dependent upon perivascular adipose tissue in women Rick I. MeijerErik H. SernéEtto C. Eringa Article Open access 24 May 2015 Pages: 1907 - 1915
Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial Keith G. McCormickEleonora ScorlettiChristopher D. Byrne Article 29 May 2015 Pages: 1916 - 1925
Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs Rozh H. Al-MashhadiMartin M. BjørklundJacob F. Bentzon Article 31 May 2015 Pages: 1926 - 1936
Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway Chi ZhangZhifeng HuangXiaokun Li Article 04 June 2015 Pages: 1937 - 1948
Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice Dong ZhengJian MaTianqing Peng Article 21 May 2015 Pages: 1949 - 1958
Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients: additional data regarding cause of death Shiva ReddyNina ZengFiona Wu Letter 31 May 2015 Pages: 1959 - 1959
Variable effects of statins on glucose homeostasis parameters and their diabetogenic role Michael S. KostapanosAris P. AgouridisMoses S. Elisaf Letter 31 May 2015 Pages: 1960 - 1961
Variable effects of statins on glucose homeostasis parameters and their diabetogenic role. Reply to Kostapanos MS, Agouridis AP and Elisaf MS [letter] Henna CederbergMarkku Laakso Letter 25 June 2015 Pages: 1962 - 1963
